Sun Pharma Advanced Research Company Limited

Web: sparc.life NSE: SPARC BSE: 532872 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

213 1(-1%)

Volume

51L as on 24, Jun

Open

161

High

203

Low

200

214

VWAP

233

52 Week High

289

52 Week Low

108

Viand Research Rating

Quality Score

61/100

Growth Score

100/100

Valuation Score

50/100

Momentum Score

70/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

6,906

No. of Shares

32.4

P/E

-16.14

P/B

-83.39

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

516.23

ROCE

Profit Growth

Listing Date

18-Jul-07

Promoter Holding

65.67%

FII Holding

2.04%

DII Holding

0.88%

Price Chart

Price Performance

1 Week5%

1 Month8%

3 Months103%

6 Months82%

1 Year42%

YTD82%

Moving Average

5 Day SMA236

10 Day SMA232

20 Day SMA220

30 Day SMA210

50 Day SMA186

61 Day SMA175

80 Day SMA156

200 Day SMA174

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	253	238	249	251
Resistance 2	249	237	245	248
Resistance 1	242	236	242	240
Pivot Point	238	235	238	237
Support 1	231	234	234	230
Support 2	227	233	231	226
Support 3	220	232	227	219

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 65.67%	(0.01) 65.67%	(0.01) 65.67%	(0.01) 65.67%	(0.01) 65.68%	(0.01) 65.68%	(0.01) 65.68%	(0.01) 65.68%	(0.01) 65.68%	(0.01) 65.68%	(0.01) 65.68%	(0.01) 65.68%	(-2.61) 65.68%	(-0.91) 68.23%	(0.01) 69.09%	(0.01) 69.09%	(1.01) 69.09%	(0.01) 68.10%	(0.01) 68.10%
FIIs	(0.01) 2.04%	(0.31) 2.04%	(0.31) 1.76%	(0.01) 1.47%	(-0.81) 1.45%	(0.11) 2.23%	(-0.51) 2.15%	(-0.61) 2.64%	(-0.11) 3.24%	(-0.41) 3.30%	(0.01) 3.67%	(0.01) 3.64%	(0.21) 3.64%	(1.11) 3.48%	(0.01) 2.38%	(0.01) 2.40%	(-0.11) 2.38%	(0.01) 2.51%	(0.01) 2.54%
DIIs	(0.11) 0.88%	(-0.31) 0.78%	(0.11) 1.05%	(-0.21) 0.97%	(0.51) 1.13%	(0.41) 0.64%	(0.01) 0.21%	(-0.51) 0.17%	(0.01) 0.67%	(0.01) 0.67%	(0.01) 0.65%	(0.01) 0.63%	(-0.11) 0.63%	(0.01) 0.76%	(0.01) 0.76%	(0.01) 0.76%	(0.21) 0.76%	(0.01) 0.55%	(0.01) 0.56%
Public	31.41%	31.51%	31.52%	31.88%	31.76%	31.47%	31.96%	31.51%	30.41%	30.36%	29.99%	30.06%	30.04%	27.53%	27.77%	27.75%	27.77%	28.84%	28.81%
No. of Shareholders	140,625	144,810	136,997	140,724	142,864	131,034	128,205	125,184	102,743	103,990	101,433	100,807	98,777	96,337	93,718	94,494	92,736	95,039	94,834

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Sales	1853	8	8	10	27	15	13	17	17	14	21	24	48
Sales Growth % (YoY)	6716%	-43%	-39%	-43%	64%	8%	-39%	-30%	-65%	-	-	-	-
Sales Growth % (QoQ)	23062.5%	-	-20%	-63%	80%	15.4%	-23.5%	-	21.4%	-33.3%	-12.5%	-50%	-
Expenses	80	65	74	62	80	89	116	110	122	116	113	126	137
Operating Profit	1773	-57	-66	-52	-53	-74	-103	-93	-106	-103	-91	-102	-90
OPM %	96	-670	-836	-540	-196	-494	-800	-555	-639	-740	-432	-427	-188
Other Income	2	-12	0	9	0	0	0	2	4	6	8	10	11
Interest	12	9	8	6	5	3	1	1	1	0	0	0	0
Depreciation	2	3	3	3	3	3	3	3	3	3	3	3	3
Profit before tax	1761	-80	-76	-52	-61	-79	-107	-96	-105	-100	-86	-95	-82
Tax %	0	0	0	0	-1	0	0	0	0	0	0	0	0
Net Profit	1761	-80	-76	-52	-60	-80	-107	-96	-106	-100	-86	-95	-82
Net Profit Growth % (QoQ)	2301.2%	-5.3%	-46.2%	13.3%	25%	25.2%	-11.5%	9.4%	-6%	-16.3%	9.5%	-15.9%	-
Net Profit Growth % (YoY)	3035%	-	29%	45.8%	43.4%	20%	-24.4%	-1.1%	-29.3%	-	-	-	-
TTM Net Profit	1553	-268	-268	-299	-343	-389	-409	-388	-387	-363	-263	-177	0
EPS in Rs	54.27	-2.48	-2.34	-1.6	-1.84	-2.45	-3.31	-2.96	-3.26	-3.07	-2.66	-2.94	-2.53

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Sales	1879	72	76	239
Sales Growth %	2518%	-5%	-68%	-
Expenses	280	395	478	453
Operating Profit	1599	-323	-402	-214
OPM %	85	-450	-532	-90
Other Income	-1	2	29	11
Interest	34	9	2	8
Depreciation	10	12	13	12
Profit before tax	1553	-343	-387	-223
Tax %	0	0	0	0
Net Profit	1553	-343	-387	-223
Net Profit Growth %	552.8%	11.4%	-73.5%	-
EPS in Rs	47.86	-10.55	-11.93	-6.86
Dividend Payout %	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Cash from Operating Activity	-239	-360	-429	-69
Cash from Investing Activity	-24	158	392	-548
Cash from Financing Activity	261	199	42	617
Net Cash Flow	-1	-3	5	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Mar 2024	Mar 2023
Equity Capital	32	32	32	32	32
Reserves	1306	-377	-249	93	480
Borrowings	559	417	269	61	16
Other Liabilities	273	250	284	328	302
Total Liabilities	2171	322	336	515	830
Fixed Assets	157	162	99	108	106
CWIP	0	1	54	44	27
Investments	0	0	0	2	291
Other Assets	2014	160	183	362	406
Total Assets	2171	322	336	515	830

Delivery

#	Date	158 83% 289	Value (Cr)	Q/T 128	Del 33	Del 59
1	22-Jul	214	45	67	41	18
2	21-Jul	225	30	73	40	12
3	20-Jul	228	32	62	44	14
4	17-Jul	235	66	58	33	22
5	16-Jul	250	20	50	39	8
6	15-Jul	251	37	62	40	15
7	14-Jul	248	49	69	43	21
8	13-Jul	259	40	63	42	17
9	10-Jul	265	78	59	37	29
10	9-Jul	278	85	75	30	25
11	8-Jul	270	230	69	22	51
12	7-Jul	266	178	72	22	39
13	6-Jul	262	248	99	31	76
14	3-Jul	239	23	73	42	10
15	2-Jul	239	23	77	36	8
16	1-Jul	238	36	91	45	16
17	30-Jun	235	28	93	44	13
18	29-Jun	231	41	81	32	13
19	25-Jun	225	47	90	36	17
20	24-Jun	227	122	99	27	33
21	23-Jun	235	49	91	30	15
22	22-Jun	238	30	90	35	10
23	19-Jun	238	45	105	33	15
24	18-Jun	242	150	88	27	41
25	17-Jun	240	75	105	39	29
26	16-Jun	238	76	105	41	31
27	15-Jun	229	92	92	32	29
28	12-Jun	224	177	156	33	58
29	11-Jun	204	47	104	31	15
30	10-Jun	206	44	109	27	12
31	9-Jun	209	68	206	59	40
32	8-Jun	204	46	116	30	14
33	5-Jun	213	78	131	26	20
34	4-Jun	213	69	141	27	18
35	3-Jun	208	99	145	25	25
36	2-Jun	204	141	148	25	35
37	1-Jun	196	129	128	32	41
38	29-May	212	109	145	27	30
39	27-May	221	243	149	25	61
40	26-May	236	901	146	12	111
41	25-May	233	1380	140	6	82
42	22-May	210	659	132	13	87
43	21-May	180	80	105	25	20
44	20-May	184	162	100	20	32
45	19-May	180	771	128	8	65
46	18-May	162	22	69	35	8
47	15-May	164	20	73	40	8
48	14-May	170	25	73	33	8

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	6,906c	30c	0.43
22-Jul	6,935c	353c	4.85
21-Jul	7,289c	370c	4.83
17-Jul	7,658c	497c	6.09
16-Jul	8,155c	7c	0.08
15-Jul	8,161c	23c	0.28
14-Jul	8,139c	293c	3.48
13-Jul	8,432c	378c	4.29
10-Jul	8,809c	214c	2.37
09-Jul	9,023c	294c	3.36
08-Jul	8,729c	156c	1.82
07-Jul	8,573c	29c	0.34
06-Jul	8,544c	811c	10.49
02-Jul	7,733c	1c	0.02
01-Jul	7,734c	108c	1.42
30-Jun	7,626c	175c	2.35
29-Jun	7,451c	166c	2.27
26-Jun	7,285c	97c	1.31
25-Jun	7,382c	30c	0.41
24-Jun	7,352c	258c	3.39
23-Jun	7,610c	105c	1.36
22-Jun	7,714c	12c	0.16
19-Jun	7,726c	51c	0.66
17-Jun	7,777c	22c	0.28
16-Jun	7,756c	325c	4.37
15-Jun	7,431c	145c	2.00
12-Jun	7,286c	393c	5.70
11-Jun	6,893c	60c	0.88
10-Jun	6,833c	0	0

Stock Checklist

Price is above from 52 week high low average: 16%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 14 fund scheme(s) across 5 fund house(s) as of Jul26 · Total value ₹8 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Motilal Oswal Mutual Fund	4	0.09%	-	7.9
Bandhan Mutual Fund	4	0.06%	-	0
Groww Mutual Fund	2	0.01%	-	0
Angel One Mutual Fund	2	0.01%	-	0
Mirae Asset Mutual Fund	2	0.01%	-	0

Sun Pharma Advanced Research Company Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements